Agilysys (NASDAQ:AGYS) disclosed on Thursday that director Michael Kaufman sold ~95.8K common shares at an
Summary: Comparing British American Tobacco and Altria reveals no clear winner; the most suitable choice
Summary: Medtronic’s recent earnings report has boosted investor confidence, suggesting the worst may be over
Summary: AbbVie is set to acquire ImmunoGen for $10.1 billion, gaining Elahere, a promising ovarian
pcess609 Affimed N.V. (NASDAQ:AFMD) shares lost ~13% on Thursday after the German biotech announced that
Summary: 3M’s stock has faced significant pressure since 2020 following the Earplug Lawsuit, erasing all
Summary: Tech stock valuations are becoming less compelling, but not in bubble territory. Julian Lin
Summary: As a Dividend King with six decades of dividend growth to its credit and
Summary: AbbVie Inc. is set to acquire drug developer ImmunoGen, Inc. for $10.1 billion, diversifying
Summary: 3M has a string of decent quarterly earnings beats and stock price reactions. With